(Q45856648)

17 December 2017

title

The effect of hypoxia on the uptake, replication and lytic potential of group B adenovirus type 3 (Ad3) and type 11p (Ad11p). (English)

1 reference

17 December 2017

0 references

1 reference

B H Shen

1

1 reference

17 December 2017

M Bauzon

series ordinal

2

1 reference

17 December 2017

T W Hermiston

series ordinal

3

1 reference

17 December 2017

publication date

9 March 2006

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

13

1 reference

17 December 2017

issue

12

1 reference

17 December 2017

page(s)

986-990

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.gt.3302736

exact match

0 references

cites work

Cancer gene therapy by adenovirus-mediated gene transfer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302736

Replication-selective oncolytic adenoviruses: virotherapy aimed at genetic targets in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302736

Impact of preexisting and induced humoral and cellular immune responses in an adenovirus-based gene therapy phase I clinical trial for localized mesothelioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302736

Determination of molecules regulating gene delivery using adenoviral vectors in ovarian carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302736

Recombinant adenovirus-mediated cytotoxic gene therapy of lymphoproliferative disorders: is CAR important for the vector to ride?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302736

Coxsackievirus-adenovirus receptor expression in ovarian cancer cell lines is associated with increased adenovirus transduction efficiency and transgene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302736

Novel replication-incompetent vector derived from adenovirus type 11 (Ad11) for vaccination and gene therapy: low seroprevalence and non-cross-reactivity with Ad5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302736

Development of adenovirus serotype 35 as a gene transfer vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302736

Development of an adenoviral vector system with adenovirus serotype 35 tropism; efficient transient gene transfer into primary malignant hematopoietic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302736

Human adenovirus type 35: nucleotide sequence and vector development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302736

Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: efficient human cell infection and bypass of preexisting adenovirus immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302736

Characterization of in vitro and in vivo gene transfer properties of adenovirus serotype 35 vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302736

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302736

Efficient gene transfer into human CD34(+) cells by a retargeted adenovirus vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302736

The human membrane cofactor CD46 is a receptor for species B adenovirus serotype 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302736

Adenovirus type 11 uses CD46 as a cellular receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302736

Obstacles to cancer immunotherapy: expression of membrane complement regulatory proteins (mCRPs) in tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302736

Hypoxia reduces adenoviral replication in cancer cells by downregulation of viral protein expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302736

Effect of hypoxia on Ad5 infection, transgene expression and replication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302736

There are two different species B adenovirus receptors: sBAR, common to species B1 and B2 adenoviruses, and sB2AR, exclusively used by species B2 adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302736

Deletion of penton RGD motifs affects the efficiency of both the internalization and the endosome escape of viral particles containing adenovirus serotype 5 or 35 fiber knobs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302736

Oncolytic effects of adenovirus mutant capable of replicating in hypoxic and normoxic regions of solid tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302736

Cancer therapy with a replicating oncolytic adenovirus targeting the hypoxic microenvironment of tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302736

A novel hypoxia-inducible factor (HIF) activated oncolytic adenovirus for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302736

Prevalence of neutralizing antibodies to adenoviral serotypes 5 and 35 in the adult populations of The Gambia, South Africa, and the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302736

inferred from DOI database lookup

7 January 2021

based on heuristic

Circumvention of anti-adenovirus neutralizing immunity by administration of an adenoviral vector of an alternate serotype

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302736

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.GT.3302736

1 reference

17 December 2017

Dimensions Publication ID

1013270653

0 references

1 reference

17 December 2017